Please login below, for login help
A reliable investment strategy: Identify a widely diversified portfolio of high-quality stocks and build up additional holdings at favorable prices.
DRIPs can help you do that.
Even small investors can follow such a strategy by investing through dividend reinvestment plans (DRIPs). That's because it takes ownership of only a single share of company stock to establish an account. Therefore, there is nothing to stop you from buying companies in a variety of industries.
As for buying at favorable prices, dollar-cost averaging virtually assures that you will buy most shares at favorable prices. And DRIPs provide an excellent way to dollar-cost average. These plans allow you to invest cash amounts to buy shares directly from the company. Once you are enrolled in a plan, you can invest amounts of as little as $25 or $50 (or as much as you can afford) to buy shares or fractions of shares. That's different than the traditional way to invest, which is to pay brokerage fees to buy a certain number of shares.
Pfizer Inc. (PFE)
Available from the Temper Enrollment Service: Yes
Last Update On: 01/07/2021:
Pfizer Inc. develops, manufactures, and sells healthcare products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and pain under the Eliquis, Chantix/Champix, and Premarin family brands biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Sutent, Xtandi, Xalkori, Inlyta, Braftovi + Mektovi brands and sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Vfend, and Zithromax brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, and tick-borne encephalitis under the Prevnar 13/Prevenar 13 (pediatric/adult), FSME-IMMUN, Nimenrix, and Trumenba brands biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, and Eucrisa brands and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, Genotropin, and Refacto AF/Xyntha brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company, Astellas Pharma US, Inc., and Myovant Sciences Ltd. a licensing agreement with Akcea Therapeutics, Inc a strategic alliance with Verily Life Sciences LLC collaboration agreements with Merck KGaA and Valneva SE a clinical trial collaboration and supply agreement with IDEAYA Biosciences, Inc. collaboration agreement with BioNTech SE a clinical supply collaboration with Jiangsu Alphamab Biopharmaceuticals Co., Ltd a research collaboration and license agreement with BioInvent International AB a drug discovery collaboration with Sosei Group Corporation and collaboration with LianBio. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York. **Taken from Yahoo Finance**
| Industry: | Drugs, consumer products |
| Minimum Investment: | $50.00 |
| Maximum Investment: | $120,000/year |
| Shares to qualify: | 1 |
| Recent Price: | 36.70 |
| Investing Fee: | $5+5¢/sh. |
| Fee for Dividends: | 5% of amount reinvested up to a max of $3.00 |
! = Company pays fees
Information is based on an annual survey and updated when company changes become available.